"Dr.Mark Buchfuhrer is Board Certified in Internal Medicine, Pulmonary Diseases & Sleep Disorders"

During the past decade, Mark Buchfuhrer, M.D. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mark Buchfuhrer, M.D." are "Narcolepsy" (2 trials) and "Sleep Apnea, Obstructive" (2 trials). Many other conditions were trialed in "Mark Buchfuhrer, M.D." in a lesser frequency.

Most popular intervention types in "Mark Buchfuhrer, M.D." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Modafinil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Mark Buchfuhrer, M.D." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mark Buchfuhrer, M.D.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mark Buchfuhrer, M.D., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mark Buchfuhrer, M.D., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".